In Combination with KEYTRUDA as Therapy for Previously Treated Patients with Advanced and/or Metastatic non-MSI-H/pMMR Endometrial Carcinoma Tokyo, August 05,…
Mumbai, August 04, 2018: Aurobindo Pharma said on 5 June it has received approval from the US Food and Drug…
Shanghai, July 29, 2018: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API)…
New Delhi, June 20, 2018: Drug major Cipla on Tuesday said it has received approval from the US health regulator to market Efavirenz…
The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval Shanghai, May 11,…
Mumbai, March 15, 2018: Pharma Major, Panacea Biotec Ltd. has announced the receipt of Establishment Inspection Report (EIR) from the…
New Delhi, March 14, 2018: Tuberculosis (TB) is an infectious disease variously named consumption, white plague, phthisis, or scrofula. It has…
New Delhi, March 08, 2018: Sun Pharma, India’s largest drug maker, is well poised to resolve the US FDA’s warning…
Mumbai, March 07, 2018: Pharma Major, Aurobindo Pharma clarifies on News Items on Company unit 4 getting 9 observation after USFDA…
Mumbai, March 04, 2018: Laurus Labs Ltd said that the USFDA audit has been successfully completed without observations – ZERO…